European Companies Search Engine
UK funding (£744,546): STEP - Scalable Technology for the Extraction of Pharmaceuticals Ukri 1 Sept 2009 UK Research and Innovation, United Kingdom
Overview
Text
STEP - Scalable Technology for the Extraction of Pharmaceuticals
| Abstract | The aim of the project is to drive substantial cost efficiency in both drug development and drug manufacturing processes by developing commercial counter current separation technology which will allow selective purifications to be achieved at a loading of approximately 1kg/day. In contrast to high-performance liquid chromatography, counter current separations do not require expensive packing materials; are more tolerant of particulate matter and have the benefit of excellent reproducibility. The project will demonstrate the broad applicability of the technology to pharmaceutical separation problems and specific examples will be more closely examined demonstrating separation capability at scale. |
| Category | Collaborative R&D |
| Reference | 100733 |
| Status | Closed |
| Funded period start | 01/09/2009 |
| Funded period end | 31/08/2012 |
| Funded value | £744,546.00 |
| Source | https://gtr.ukri.org/projects?ref=100733 |
Participating Organisations
| GLAXOSMITHKLINE PLC |
£67,920.00 |
| BRUNEL UNIVERSITY LONDON |
£396,719.00 |
| PFIZER LIMITED |
£1,000.00 |
| DYNAMIC EXTRACTIONS LIMITED |
£278,907.00 |
The filing refers to a past date, and does not necessarily reflect the current state. The latest known state is available on the following page: GSK plc, London.